The Proceedings of the American Thoracic Society 2:110-115 (2005)
© 2005 The American Thoracic Society
Pathogenesis of Respiratory Syncytial Virus Infection in the Murine Model
R. Stokes Peebles, Jr. and
Barney S. Graham
Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee; and Vaccine Research Center, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, Maryland
Correspondence and requests for reprints should be addressed to Barney Graham, M.D., Ph.D., Vaccine Research Center, NIAID/NIH, 40 Convent Drive, Building 40, Room 2502, Bethesda, MD 20892-3017. E-mail: bgraham{at}nih.gov
There is a wide spectrum of illness caused by respiratory syncytial virus (RSV) infection that is caused in large part by host-related factors, such as age of the patient and degree of host immunocompetency. Although the vast majority of persons infected with RSV experience symptoms of mild upper respiratory tract infection, in some people these infections cause significant morbidity and are sometimes fatal. Although a great deal of investigation in both humans and animals has explained the timing and tropism of RSV infection and the general principles by which the immune system responds to this infection, at present we only partially understand the disparity in illness severity that can occur. This article briefly reviews the clinical sequelae of RSV infection and then focuses on the mechanisms of viral pathogenesis.
Key Words: airway hyperreactivity interleukin-17 mucus pathology T cells
This article has been cited by other articles:

|
 |

|
 |
 
S. S. Mohapatra and S. Boyapalle
Epidemiologic, Experimental, and Clinical Links between Respiratory Syncytial Virus Infection and Asthma
Clin. Microbiol. Rev.,
July 1, 2008;
21(3):
495 - 504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Eckardt-Michel, M. Lorek, D. Baxmann, T. Grunwald, G. M. Keil, and G. Zimmer
The Fusion Protein of Respiratory Syncytial Virus Triggers p53-Dependent Apoptosis
J. Virol.,
April 1, 2008;
82(7):
3236 - 3249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Melendi, F. R. Laham, A. C. Monsalvo, J. M. Casellas, V. Israele, N. R. Polack, S. R. Kleeberger, and F. P. Polack
Cytokine Profiles in the Respiratory Tract During Primary Infection With Human Metapneumovirus, Respiratory Syncytial Virus, or Influenza Virus in Infants
Pediatrics,
August 1, 2007;
120(2):
e410 - e415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Singh, K. L. McCann, and F. Imani
MAPK and heat shock protein 27 activation are associated with respiratory syncytial virus induction of human bronchial epithelial monolayer disruption
Am J Physiol Lung Cell Mol Physiol,
August 1, 2007;
293(2):
L436 - L445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Singh, P. E. Moore, J. E. Gern, R. F. Lemanske Jr., and T. V. Hartert
Bronchiolitis to Asthma: A Review and Call for Studies of Gene-Virus Interactions in Asthma Causation
Am. J. Respir. Crit. Care Med.,
January 15, 2007;
175(2):
108 - 119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Smit, B. D. Rudd, and N. W. Lukacs
Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus
J. Exp. Med.,
May 15, 2006;
203(5):
1153 - 1159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Bridges, Y. Xu, C.-L. Na, H. R. Wong, and T. E. Weaver
Adaptation and increased susceptibility to infection associated with constitutive expression of misfolded SP-C
J. Cell Biol.,
January 30, 2006;
172(3):
395 - 407.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Thoracic Society.
|
|
|